Glaucoma is the second most common cause of blindness in the United States, and an estimated 1 million people in the U.S. over the age of 65 have glaucoma-related vision loss. Treating glaucoma in its early stages is the only way to slow down further vision loss from the condition, so it’s important for patients to be aware of this condition and its risks.
With January being Glaucoma Awareness Month, let’s discuss this condition and the available treatment options for it.
What is Glaucoma?
Glaucoma is a condition involving damage to the optic nerve. The optic nerve delivers messages from the retina to the brain, and it’s crucial for healthy vision. When optic nerve damage occurs with glaucoma, vision loss can occur.
Elevated eye pressure is the most common cause of glaucoma. Eye pressure often increases as a result of fluid buildup. When the eye produces too much fluid (aqueous humor) or the eye drainage system is malfunctioning, the fluid accumulates and raises the pressure in the eye.
Risk Factors
Having a family history of glaucoma leads to a heightened risk of developing the condition. Other risk factors include:
- Being aged 60 or over
- Having medical conditions including diabetes, high blood pressure, sickle cell anemia, and heart disease
- Being very farsighted or nearsighted
- Having an eye injury
- Using corticosteroid medications for an extended period
XEN Gel Stent for Glaucoma
At The Eye Clinic of Florida, we offer Xen Gel Stent for glaucoma. Dr. Mahootchi has performed the most XEN Gel Stents in the United States, and this innovative procedure can successfully reduce the pressure in the eyes without the negative aspects of other glaucoma treatments. Early treatment with XEN Gel implants can slow down vision loss from glaucoma.
To learn more, schedule an appointment with us today!